Extreme Movers: Perplexity's picks for 2026-10-09
Perplexity picked HUM, COHR, VZ, DAL, LITE for a 1-day horizon. Average directional return: -2.12%. Directions called correctly: 0%.
| Experiment | Extreme Movers |
|---|---|
| Model | Perplexity |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-09 |
| Measured to | 2026-10-12 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -2.12% |
| Directions called correctly | 0% |
| Benchmark return | +0.22% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | HUM | up | -0.40% | -0.40% | 72% | -0.62% | No |
| 2 | COHR | up | -3.03% | -3.03% | 60% | -3.25% | No |
| 3 | VZ | up | -0.21% | -0.21% | 55% | -0.43% | No |
| 4 | DAL | down | +0.09% | -0.09% | 62% | -0.31% | No |
| 5 | LITE | up | -6.85% | -6.85% | 52% | -7.07% | No |
The model's market view
US equities enter the October 9 session with a rebound bias after Thursday's AI-led selloff, but single-stock catalysts dominate: Humana's Medicare Advantage star-rating upgrade is substantive, optical stocks are responding to a capacity-demand claim, while telecoms and Delta face material competitive and earnings headwinds. I favor continuation in fundamentally supported gainers, a tactical reversal in oversold Verizon, and continuation lower in Delta after its guidance cut.
Why each pick
HUM
Humana is the strongest substantive gainer: CMS's improved 2027 Medicare Advantage Star Ratings restored bonus-payment eligibility for a major contract, and Baird upgraded the stock while raising its target. The move was +15.97% in premarket trading, so I expect continuation higher into the close as insurers and analysts reprice the earnings implications. Risks are a fast mean-reversion after an outsized gap and broader managed-care weakness. Quote used: Nasdaq real-time premarket price at 8:34 AM ET on 2026-10-09; 20-day average dollar volume is estimated from Yahoo's reported 20-day average share volume of 1,260,607 multiplied by the quoted price.
COHR
Coherent rebounded 3.49% premarket after falling 9.63% in the prior regular session, tracking Lumentum's statement that optical components are effectively sold out through early 2029. The catalyst is partly substantive demand commentary but also a bounce from an oversold AI-optics selloff, so I classify it as continuation with moderate conviction. A renewed rise in yields or further AI-capital-spending doubts could reverse the bounce. Quote used: NYSE real-time premarket price at 5:47 AM ET on 2026-10-09; 20-day average dollar volume is estimated from Yahoo's reported average volume of 6,439,939 shares multiplied by the quoted price.
VZ
Verizon fell 5.78% overnight after SpaceX's spectrum acquisition raised the prospect of satellite-based wireless competition. The concern is real but its immediate financial impact is uncertain and multi-year, while Verizon entered the session with a 6.18% forward dividend yield and a market cap near $193 billion; I expect a partial reversal higher as the initial gap-down stabilizes. Main risk is that investors treat the SpaceX threat as structurally negative and keep pressuring the shares. Quote used: NYSE/BOATS overnight price at 12:03 AM ET on 2026-10-09, the freshest quote available before the regular open; 20-day average dollar volume is estimated from Yahoo's reported average volume of 21,909,901 shares multiplied by the quoted price.
DAL
Delta reported Q3 EPS of $1.72 versus a $1.76 estimate and cut its annual profit outlook as fuel costs surged 62% year over year. This is a substantive fundamental catalyst, and the stock was down 4.84% premarket; I expect continuation lower as investors digest the reduced guidance and the earnings call. Risk: strong travel-demand commentary or a broad market rebound could limit the decline. Quote used: NYSE real-time premarket price at 7:13 AM ET on 2026-10-09; 20-day average dollar volume is estimated from Yahoo's reported average volume of 6,237,926 shares multiplied by the quoted price.
LITE
Lumentum opened up 0.49% after CEO Michael Hurlston said optical components are sold out through 2029 and that the company may struggle to meet as much as 70% of demand for some products next year. The demand commentary is substantive, but the stock had already fallen in the prior session and the early regular-session move was modest, making the signal less decisive than Humana's. I still lean toward continuation higher on AI-optics demand, while recognizing high valuation and sensitivity to the broader AI trade. Quote used: Nasdaq delayed regular-session price as of 9:30:51 AM ET on 2026-10-09; 20-day average dollar volume is estimated from Yahoo's reported average volume of 4,635,693 shares multiplied by the quoted price.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| GPT-6 | HAE, ARGX, AAOI, HUT, COCO | -0.51% | 40% |
| Muse Spark 1.1 | HAE, CSGP, AAOI, MXL, ARGX | +0.31% | 60% |
| Gemini 1.5 Pro | HAE, COHR, COCO, CSGP, GLW | -0.95% | 40% |
| Grok 4.5 | HUM, CCI, TMUS, T, ASTS | +0.44% | 60% |
| Claude Sonnet 5.5 | CMG, HAE, COHR, CSGP, ORCL | +0.45% | 60% |
| DeepSeek | HUM, CCI, TMUS, T, DAL | +0.92% | 60% |
Written up on ForecastNest Insights: Extreme Movers: Perplexity's picks for 2026-10-09.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.